AI Article Synopsis
- GAN is a hereditary disease that impacts peripheral and central nervous systems, marked by the accumulation of intermediate filament aggregates and linked to mutations in the gigaxonin gene.
- Protein analysis in cell lines from GAN patients revealed dysregulation of several proteins, including key ribosomal proteins and galectin-1, but the levels of many cytoskeletal proteins remained unchanged.
- The study suggests that the disruption in cytoskeletal regulation may lead to the formation of these filament aggregates, indicating a potential mechanism behind the disease's pathology.
Article Abstract
Introduction: Giant axonal neuropathy (GAN) is a progressive hereditary disease that affects the peripheral and central nervous systems. It is characterized morphologically by aggregates of intermediate filaments in different tissues. Mutations have been reported in the gene that codes for gigaxonin. Nevertheless, the underlying molecular mechanism remains obscure.
Methods: Cell lines from 4 GAN patients and 4 controls were analyzed by iTRAQ.
Results: Among the dysregulated proteins were ribosomal protein L29, ribosomal protein L37, galectin-1, glia-derived nexin, and aminopeptidase N. Also, nuclear proteins linked to formin-binding proteins were found to be dysregulated. Although the major role of gigaxonin is reported to be degradation of cytoskeleton-associated proteins, the amount of 76 structural cytoskeletal proteins was unaltered.
Conclusions: Several of the dysregulated proteins play a role in cytoskeletal reorganization. Based on these findings, we speculate that disturbed cytoskeletal regulation is responsible for formation of aggregates of intermediate filaments.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mus.23306 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!